Nimish P. Shah - 10 Oct 2025 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Director
Signature
Nimish Shah, By: /s/ Sherman G. Souther, Attorney-infact
Issuer symbol
APGE
Transactions as of
10 Oct 2025
Net transactions value
+$14,999,936
Form type
4
Filing time
15 Oct 2025, 16:10:06 UTC
Previous filing
20 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shah Nimish P Director C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK Nimish Shah, By: /s/ Sherman G. Souther, Attorney-infact 15 Oct 2025 0001698082

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Pre-Funded Warrants (Right to Buy) Purchase $14,999,936 +365,853 $41.00 365,853 10 Oct 2025 Common Stock 365,853 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is $0.00001 per share.
F2 The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, Venrock Opportunities Fund, L.P. ("VOF") shall not be entitled to exercise the Pre-Funded Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by VOF, its affiliates and any persons whose ownership would be aggregated with VOF's for purposes of Section 13(d) of the Securities Exchange Act to exceed 4.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.
F3 Securities are held directly by VOF. Venrock Opportunities Management, LLC ("VO Management") is the general partner of VOF. The Reporting Person is a voting member of VO Management and expressly disclaims beneficial ownership over all shares held by VOF except to the extent of his indirect pecuniary interests therein.